These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 22157614)
1. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma. Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614 [TBL] [Abstract][Full Text] [Related]
2. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674 [TBL] [Abstract][Full Text] [Related]
3. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574 [TBL] [Abstract][Full Text] [Related]
5. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Lake SL; Coupland SE; Taktak AF; Damato BE Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121 [TBL] [Abstract][Full Text] [Related]
6. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma. Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594 [TBL] [Abstract][Full Text] [Related]
7. Transvitreal Retinochoroidal Biopsy Provides a Representative Sample From Choroidal Melanoma for Detection of Chromosome 3 Aberrations. Bagger M; Andersen MT; Heegaard S; Andersen MK; Kiilgaard JF Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5917-24. PubMed ID: 26377078 [TBL] [Abstract][Full Text] [Related]
8. Cytogenetics of uveal melanoma: a 7-year clinical experience. Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643 [TBL] [Abstract][Full Text] [Related]
9. Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification. Dopierala J; Damato BE; Lake SL; Taktak AF; Coupland SE Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4898-905. PubMed ID: 20484589 [TBL] [Abstract][Full Text] [Related]
10. Multiplex ligation-dependent probe amplification analysis of uveal melanoma with extraocular extension demonstrates heterogeneity of gross chromosomal abnormalities. Lake SL; Damato BE; Dopierala J; Baudo MM; Taktak AF; Coupland SE Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5559-64. PubMed ID: 21659309 [TBL] [Abstract][Full Text] [Related]
11. Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome. Ewens KG; Kanetsky PA; Richards-Yutz J; Al-Dahmash S; De Luca MC; Bianciotto CG; Shields CL; Ganguly A Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5721-9. PubMed ID: 23821189 [TBL] [Abstract][Full Text] [Related]
12. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma. Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523 [TBL] [Abstract][Full Text] [Related]
13. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization. Parrella P; Caballero OL; Sidransky D; Merbs SL Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428 [TBL] [Abstract][Full Text] [Related]
14. [Genomic techniques used in uveal melanoma: a literature review]. Abi-Ayad N; Kodjikian L; Couturier J J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677 [TBL] [Abstract][Full Text] [Related]
15. Clinical and cytogenetic analyses in uveal melanoma. Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076 [TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662 [TBL] [Abstract][Full Text] [Related]
17. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859 [TBL] [Abstract][Full Text] [Related]
18. Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8. van Gils W; Kilic E; Brüggenwirth HT; Vaarwater J; Verbiest MM; Beverloo B; van Til-Berg ME; Paridaens D; Luyten GP; de Klein A Melanoma Res; 2008 Feb; 18(1):10-5. PubMed ID: 18227702 [TBL] [Abstract][Full Text] [Related]
19. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972 [TBL] [Abstract][Full Text] [Related]
20. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Damato B; Dopierala J; Klaasen A; van Dijk M; Sibbring J; Coupland SE Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3048-55. PubMed ID: 19182252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]